摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-(4-bromophenyl)-2-oxoethyl]-1,2-dimethylimidazolium bromide | 16930-53-3

中文名称
——
中文别名
——
英文名称
3-[2-(4-bromophenyl)-2-oxoethyl]-1,2-dimethylimidazolium bromide
英文别名
1-(4-Bromophenyl)-2-(2,3-dimethylimidazol-3-ium-1-yl)ethanone;bromide
3-[2-(4-bromophenyl)-2-oxoethyl]-1,2-dimethylimidazolium bromide化学式
CAS
16930-53-3
化学式
Br*C13H14BrN2O
mdl
——
分子量
374.075
InChiKey
DCXCFGPLEGWHOJ-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.73
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    25.9
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Method for treating fibrotic diseases or other indications IC
    申请人:Alteon, Inc.
    公开号:US20020068729A1
    公开(公告)日:2002-06-06
    Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I: 1
    提供了一种处理、改善或预防动物包括人类发明的指示的方法,包括给予公式I的化合物的有效量:1
  • Method for treating fibrotic diseases or other indications with imidazolium agents
    申请人:Alteon, Inc.
    公开号:US20030176426A1
    公开(公告)日:2003-09-18
    Provided is a method of treating or ameliorating an indication of the invention in an animal, including a human, by administering an effective amount of a compound of the formula I: 1 wherein R 1 , R 2 , M, X and Z are as described supra. Also provided are certain imidazolium compounds and pharmaceutical compositions containing the imidazolium compounds.
    提供了一种治疗或改善动物(包括人类)发明的征兆的方法,通过给予公式I的有效量的化合物: 1 其中R 1 ,R 2 ,M,X和Z如上所述。还提供了一些咪唑啉化合物和包含咪唑啉化合物的药物组合物。
  • Method for treating fibrotic diseases or other indications IE
    申请人:——
    公开号:US20040235837A1
    公开(公告)日:2004-11-25
    Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I: 1
    提供了一种治疗、改善或预防发明所示迹象的方法,在动物中包括人类,该方法包括给予化合物I的有效剂量:1。
  • Method for treating glaucoma IC
    申请人:——
    公开号:US20020160993A1
    公开(公告)日:2002-10-31
    Provided is a method of treating or ameliorating or preventing glaucoma, decreasing intraocular pressure or improving or amemliorting ocular accommodation in an animal, including a human comprising administering an intraocular pressure decreasing or accommodation improving amount of a compound of the formula I: 1
    提供了一种治疗、改善或预防青光眼、降低眼压或改善或缓解动眼调节的方法,包括在动物(包括人类)中给予化合物I的降低眼压或改善动眼调节的剂量。
  • Method for treating diabetic nephropathy
    申请人:Egan John
    公开号:US20090124673A1
    公开(公告)日:2009-05-14
    Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I:
    提供的是一种治疗、改善或预防本发明适应症的动物,包括人类的方法,其中包括给予化合物I的有效剂量。
查看更多